Top

Published in:

Open Access 01-02-2017 | Original Article

Transcatheter closure of paravalvular leaks: state of the art

Authors: I. Cruz-Gonzalez, J. C. Rama-Merchan, J. Rodríguez-Collado, J. Martín-Moreiras, A. Diego-Nieto, M. Barreiro-Pérez, P. L Sánchez

Published in: Netherlands Heart Journal | Issue 2/2017

Abstract

Paravalvular leak (PVL) is a serious complication after surgical valve replacement or after transcatheter aortic valve replacement. Approximately 1–5% of PVLs can lead to serious clinical consequences, including congestive heart failure and/or haemolytic anaemia. For years, surgical re-intervention has been considered the treatment of choice for symptomatic patients with PVLs. However, surgical re-intervention is associated with a high risk of morbidity and mortality. Transcatheter PVL (TPVL) closure is a less invasive alternative to surgical re-intervention. The safety and feasibility of TPVL closure has been confirmed in several registries and a meta-analysis.

In this review, we discuss the clinical implications and diagnosis of PVLs, technical considerations for TPVL, execution of the procedure and assessment of the results.

Jindani A, Neville EM, Venn G, et al. Paraprosthetic leak: a complication of cardiac valve replacement. J Cardiovasc Surg [Torino]. 1991;32:503–8.

Saia F, Martinez C, Gafoor S, et al. Long-term outcomes of percutaneous paravalvular regurgitation closure after transcatheter aortic valve replacement: a multicenter experience. JACC Cardiovasc Interv. 2015;8:681–8.CrossRefPubMed

Ionescu A, Fraser AG, Butchart EG. Prevalence and clinical significance of incidental paraprosthetic valvar regurgitation: a prospective study using transoesophageal echocardiography. Heart. 2003;89:1316–21.CrossRefPubMedPubMedCentral

Genoni M, Franzen D, Vogt P, et al. Paravalvular leakage after mitral valve replacement: improved long-term survival with aggressive surgery? Eur J Cardiothorac Surg. 2000;17:14–9.CrossRefPubMed

Abdel-Wahab M, Zahn R, Horack M, et al. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart. 2011;97:899–906.CrossRefPubMed

Pate GE, Al Zubaidi A, Chandavimol M, Thompson CR, Munt BI, Webb JG. Percutaneous closure of prosthetic paravalvular leaks: case series and review. Catheter Cardiovasc Interv. 2006;68:528–33.CrossRefPubMed

Rallidis LS, Moyssakis IE, Ikonomidis I, Nihoyannopoulos P. Natural history of early aortic paraprosthetic regurgitation: a five-year follow-up. Am Heart J. 1999;138:351–7.CrossRefPubMed

Taramasso M, Maisano F, Denti P, et al. Surgical treatment of paravalvular leak: long-term results in a single-center experience (up to 14 years). J Thorac Cardiovasc Surg. 2015;149:1270–5.CrossRefPubMed

Ruiz CE, Jelnin V, Kronzon I, et al. Clinical outcomes in patients undergoing percutaneous closure of periprosthetic paravalvular leaks. J Am Coll Cardiol. 2011;58:2210–7.CrossRefPubMed

10.

Sorajja P, Cabalka AK, Hagler DJ, et al. Long-term follow-up of percutaneous repair of paravalvular prosthetic regurgitation. J Am Coll Cardiol. 2011;58:2218–24.CrossRefPubMed

11.

Sorajja P, Cabalka AK, Hagler DJ, et al. Percutaneous repair of paravalvular prosthetic regurgitation: acute and 30-day outcomes in 115 patients. Circ Cardiovasc Interv. 2011;4:314–21.CrossRefPubMed

12.

Millan X, Skaf S, Joseph L, et al. Transcatheter reduction of paravalvular leaks: a systematic review and meta-analysis. Can J Cardiol. 2015;31:260–9.CrossRefPubMed

13.

Matsumoto M, Inoue M, Tamura S, et al. Three-dimensional echocardiography for spatial visualization and volume calculation of cardiac structures. J Clin Ultrasound. 1981;9:157–65.CrossRefPubMed

14.

Singh P, Manda J, Hsiung MC, et al. Live/real time three-dimensional transesophageal echocardiographic evaluation of mitral and aortic valve prosthetic paravalvular regurgitation. Echocardiography. 2009;26:980–7.CrossRefPubMed

15.

Zamorano JL, Badano LP, Bruce C, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. Eur Heart J. 2011;32:2189–214.CrossRefPubMed

16.

Lazaro C, Hinojar R, Zamorano JL. Cardiac imaging in prosthetic paravalvular leaks. Cardiovasc Diagn Ther. 2014;4:307–13.PubMedPubMedCentral

17.

Arribas-Jimenez A, Rama-Merchan JC, Barreiro-Perez M, et al. Utility of real-time 3‑dimensional transesophageal echocardiography in the assessment of mitral paravalvular leak. Circ J. 2016;80:738–44.CrossRefPubMed

18.

Mahjoub H, Noble S, Ibrahim R, et al. Description and assessment of a common reference method for fluoroscopic and transesophageal echocardiographic localization and guidance of mitral periprosthetic transcatheter leak reduction. JACC Cardiovasc Interv. 2011;4:107–14.CrossRefPubMed

19.

Suh YJ, Hong GR, Han K, et al. Assessment of mitral paravalvular leakage after mitral valve replacement using cardiac computed tomography: comparison with surgical findings. Circ Cardiovasc Imaging. 2016;9:e004153.CrossRefPubMed

20.

Arri SS, Poliacikova P, Hildick-Smith D. Percutaneous paravalvular leak closure for symptomatic aortic regurgitation after CoreValve transcatheter aortic valve implantation. Catheter Cardiovasc Interv. 2015;85:657–64.CrossRefPubMed

21.

Cruz-Gonzalez I, Rama-Merchan JC, Calvert PA, et al. Percutaneous closure of paravalvular leaks: a systematic review. J Interv Cardiol. 2016;29:382–92.CrossRefPubMed

22.

Sanchez-Recalde A, Moreno R, Galeote G, et al. Immediate and mid-term clinical course after percutaneous closure of paravalvular leakage. Rev Esp Cardiol [Engl Ed]. 2014;67:615–23.CrossRef

23.

Cruz-Gonzalez I, Rama-Merchan JC, Arribas-Jimenez A, et al. Paravalvular leak closure with the Amplatzer vascular plug III device: immediate and short-term results. Rev Esp Cardiol [Engl Ed]. 2014;67:608–14.CrossRef

24.

Shapira Y, Hirsch R, Kornowski R, et al. Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J Heart Valve Dis. 2007;16:305–13.PubMed

25.

Goktekin O, Vatankulu MA, Tasal A, et al. Transcatheter trans-apical closure of paravalvular mitral and aortic leaks using a new device: first in man experience. Catheter Cardiovasc Interv. 2014;83:308–14.CrossRefPubMed

26.

Cortes M, Garcia E, Garcia-Fernandez MA, Gomez JJ, Perez-David E, Fernandez-Aviles F. Usefulness of transesophageal echocardiography in percutaneous transcatheter repairs of paravalvular mitral regurgitation. Am J Cardiol. 2008;101:382–6.CrossRefPubMed

27.

Noble S, Jolicoeur EM, Basmadjian A, et al. Percutaneous paravalvular leak reduction: procedural and long-term clinical outcomes. Can J Cardiol. 2013;29:1422–8.CrossRefPubMed

28.

Hein R, Wunderlich N, Robertson G, et al. Catheter closure of paravalvular leak. EuroIntervention. 2006;2:318–25.PubMed

29.

Calvert PA, Northridge D, Malik IS, et al. Percutaneous device closure of paravalvular leak: combined experience from the United Kingdom and Ireland. Circulation. 2016; doi:10.1161/cir.0000000000000466.

30.

Angulo-Llanos R, Sarnago-Cebada F, Rivera AR, et al. Two-year follow up after surgical versus percutaneous paravalvular leak closure: a non-randomized analysis. Catheter Cardiovasc Interv. 2016; doi:10.1002/ccd.26459.PubMed

Title: Transcatheter closure of paravalvular leaks: state of the art
Authors: I. Cruz-Gonzalez
J. C. Rama-Merchan
J. Rodríguez-Collado
J. Martín-Moreiras
A. Diego-Nieto
M. Barreiro-Pérez
P. L Sánchez
Publication date: 01-02-2017
Publisher: Bohn Stafleu van Loghum
Published in: Netherlands Heart Journal / Issue 2/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI: https://doi.org/10.1007/s12471-016-0918-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Transcatheter closure of paravalvular leaks: state of the art

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Left atrial appendage closure: outcomes and challenges

Structural and congenital heart disease interventions: the role of three-dimensional printing

Three dimensional rotational angiography for assessment of coronary arteries during melody valve implantation: introducing a technique that may improve outcomes

Three-dimensional image fusion guidance of percutaneous pulmonary valve implantation to reduce radiation exposure and contrast dose: A comparison with traditional two-dimensional and three-dimensional rotational angiographic guidance

MitraClip step by step; how to simplify the procedure

Safety and efficacy of transseptal puncture guided by real-time fusion of echocardiography and fluoroscopy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page